Cargando…
MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPC) is a malignancy of epithelial origin that is prone to local invasion and early distant metastasis. Although concurrent chemotherapy and radiotherapy improves the 5-year survival outcomes, persistent or recurrent disease still occurs. Therefore, novel therapeutic target...
Autores principales: | Wang, Sumei, Claret, François-Xavier, Wu, Wanyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700302/ https://www.ncbi.nlm.nih.gov/pubmed/31456943 http://dx.doi.org/10.3389/fonc.2019.00756 |
Ejemplares similares
-
MicroRNA-24 in Cancer: A Double Side Medal With Opposite Properties
por: Wang, Sumei, et al.
Publicado: (2020) -
MicroRNAs in nasopharyngeal carcinoma
por: Bruce, Jeff P., et al.
Publicado: (2014) -
MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer
por: Yang, Ying, et al.
Publicado: (2022) -
The role of microRNAs in nasopharyngeal carcinoma
por: Tan, Gongjun, et al.
Publicado: (2014) -
A Five-MicroRNA Signature Predicts the Prognosis in Nasopharyngeal Carcinoma
por: Wu, Shixiong, et al.
Publicado: (2021)